Pharmaceuticals in the Environment

  title={Pharmaceuticals in the Environment},
  author={Klaus K{\"u}mmerer},
  journal={Annual Review of Environment and Resources},
  • K. Kümmerer
  • Published 2001
  • Political Science, Biology
  • Annual Review of Environment and Resources
Pharmaceuticals are chemicals that are used because of their biological activity. They are often excreted unchanged and can reach the environment. Throughout developed countries, the pharmaceutical concentrations in the aquatic environment are in the same range (μg L−1 and below); however, it is not clear whether this holds for less-developed countries too. The health risks of active pharmaceutical ingredients (APIs) remain poorly understood. Although there are no known short-term effects on… 

Figures and Tables from this paper

Pharmaceutical Mixtures: Still A Concern For Human And Environmental Health.
It appears that numerous gaps still exist in the current knowledge related to this field of interest, and further studies should be conducted at global level in order to ensure a more efficient monitorisation of the presence of PhACs and their metabolites into the aquatic environment and to develop new mitigation measures.
Risks Related to the Discharge of Pharmaceuticals in the Environment: Further Research Is Needed
Data are scant on the amounts of the different active substances emitted into wastewater, surface water or soil, but recent investigations indicated not only that several drugs are detectable in the effluent from sewage treatment plants, but also that several are not degraded and can reach ng 1−11 and μg l−1 concentrations in rivers and drinking water.
The presence of pharmaceuticals in the environment due to human use--present knowledge and future challenges.
  • K. Kümmerer
  • Computer Science
    Journal of environmental management
  • 2009
Legislation Controlling the Discharge of Pharmaceuticals into the Environment
As stated in previous chapters, the earliest studies on quantification of pharmaceutical concentrations in the environment and induction of toxic effects on organisms date back to the 1990s. Since
Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country
New research is urgently required about the effects of pharmaceuticals in biota—including long-term exposition and mixture tests—and on specific technologies to remove these compounds in water bodies and WWTPs, besides the introduction of new policies for pharmaceutical use.
Impact of Emergent Contaminants in the Environment: Environmental Risk Assessment
A critical analysis of the available information was carried out, indicating that acute toxicity was only likely for spills, although an exception to this general behavior is shown by endocrine-active substances.
Pharmaceuticals in the Canadian Environment
One of the first reports of the release of pharmaceutically active compounds (PhACs) into the environment was a study conducted in Canada on the concentrations of selected drugs in the effluent from
Pharmaceuticals in Environment
  • A. Bali
  • Biology
    Environmental Exposures and Human Health Challenges
  • 2019
This chapter outlines the various anticipated routes of exposure of pharmaceuticals to the environment along with their detrimental effects, fate and degradation in aquatic and terrestrial environments and the role of various regulatory bodies.
The Fate and Effects of Human Pharmaceuticals in the Aquatic Environment
There is relatively little known about the fate of human pharmaceuticals once they are released into the aquatic environment and what adverse impacts these compounds have on exposed aquatic
Ecotoxicology of human pharmaceuticals.


Pharmaceuticals and personal care products in the environment: agents of subtle change?
This review attempts to synthesize the literature on environmental origin, distribution/occurrence, and effects and to catalyze a more focused discussion in the environmental science community.
Pharmaceutical antibiotic compounds in soils – a review
Antibiotics are highly effective, bioactive substances. As a result of their consumption, excretion, and persistence, they are disseminated mostly via excrements and enter the soils and other
Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.
  • C. Daughton
  • Environmental Science
    Environmental health perspectives
  • 2003
This article focuses initially on the background behind the imperative for an ecologically oriented stewardship program for PPCPs, and presents a broad spectrum of possible source control/reduction actions, controlled largely by the health care industry, that could minimize the disposition of P PCPs to the environment.
Promoting resistance by the emission of antibiotics from hospitals and households into effluent.
  • K. Kümmerer, A. Henninger
  • Medicine
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2003
The volume of antibiotics used in hospitals and private households and released into effluent and municipal sewage indicates a selection pressure on bacteria.
Occurrence and distribution of pharmaceutical organic compounds in the groundwater downgradient of a landfill (grindsted, denmark).
The occurrence and distribution of organic compounds originating from waste from the pharmaceutical industry in the groundwater downgradient of the same landfill is described, the first report on pharmaceutical compounds in a leachate plume.
Fate of pharmaceuticals during indirect potable reuse.
The antiepileptics carbamazepine and primidone represented the most dominant of all investigated drugs in well treated domestic effluents (nitrifying/denitrifying plants) and a high potential for biodegradation was also observed for anti-inflammatory drugs in groundwater recharge systems.
Something from “ Nothing ”-Eight Weak Estrogenic Chemicals Combined at Concentrations below NOECs Produce Significant Mixture Effects
It is concluded that estrogenic agents are able to act together to produce significant effects when combined at concentrations below their NOECs, highlighting the limitations of the traditional focus on the effects of single agents.
Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland.
The risk quotients obtained suggest a low probability for adverse effects of the occurring FQs, either on microbial activity in WWTPs or on algae, daphnia, and fish in surface waters, following the recommendations of the European guidelines or draft documents.